Palo Alto, CANCT06413706Now EnrollingIRB Ready

Brain tumor Clinical Trial in Palo Alto, CA

Access cutting-edge brain tumor treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.

Sponsored by Eli Lilly and Company

Quick Self-Assessment

See if you qualify for this Palo Alto location

Preparing your pre-screening questions...

Expert Care in Palo Alto

Access brain tumor specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related brain tumor treatment provided free

Apply for This Palo Alto Location

Check if you qualify for this brain tumor clinical trial in Palo Alto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Palo Alto

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Palo Alto site if eligible
  4. 4Begin participation

About This Brain tumor Study in Palo Alto

The purpose of this study is to measure the benefit of adding abemaciclib to the chemotherapy, temozolomide, for newly diagnosed high-grade glioma following radiotherapy. Your participation could last approximately 11 months and possibly longer depending upon how you and your tumor respond.

Sponsor: Eli Lilly and Company

Who Can Participate

Inclusion Criteria

Biopsy proven high-grade glioma (HGG) as defined by 2016 World Health Organization (WHO) Classification Criteria, Grade 3-4 including:
Anaplastic astrocytoma
Anaplastic ganglioglioma
Anaplastic oligodendroglioma.
Anaplastic pleomorphic xanthoastrocytoma,
Glioblastoma OR as defined by the 2021 WHO Classification Criteria as molecularly characterized:
Non-pontine diffuse midline glioma, H3 K27-altered,
Diffuse hemispheric glioma, H3 G34-mutant
Diffuse pediatric HGG, H3/IDH-wildtype
Infant-type hemispheric glioma
High-grade astrocytoma with piloid features
High-grade pleomorphic xanthoastrocytoma
IDH-mutant diffuse glioma with homozygous cyclin- dependent kinase inhibitor 2A/B (CDKN2A/B) deletion,
IDH-mutant and 1p/19q co-deleted oligodendroglioma
IDH-mutant astrocytoma with homozygous CDKN2A/B deletion
Contraceptive use should be consistent with local regulations for participants in clinical studies.
Radiotherapy initiated within 6

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Palo Alto?

Yes, this clinical trial (NCT06413706) has an active research site in Palo Alto, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Brain tumor Treatment Options in Palo Alto, CA

If you're searching for brain tumor treatment options in Palo Alto, CA, this clinical trial (NCT06413706) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all brain tumor clinical trials near you to find additional studies recruiting in your area.

More Brain Cancer Trials in Palo Alto, CA

See all brain cancer clinical trials recruiting in Palo Alto โ€” not just this study.

Browse Brain Cancer Trials in Palo Alto โ†’

Ready to Join in Palo Alto?

Take the first step toward participating in this groundbreaking clinical trial

Secure ยท Expert Care ยท Palo Alto, CA